| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 916 | 2019 |
| Caplacizumab for acquired thrombotic thrombocytopenic purpura F Peyvandi, M Scully, JA Kremer Hovinga, S Cataland, P Knöbl, H Wu, ... New England Journal of Medicine 374 (6), 511-522, 2016 | 677 | 2016 |
| Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ... Journal of Thrombosis and Haemostasis 10 (4), 622-631, 2012 | 624 | 2012 |
| Acquired hemophilia A: updated review of evidence and treatment guidance R Kruse‐Jarres, CL Kempton, F Baudo, PW Collins, P Knoebl, ... American journal of hematology 92 (7), 695-705, 2017 | 448 | 2017 |
| Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry F Baudo, P Collins, A Huth-Kuehne, H Levesque, P Marco, L Nemes, ... Blood, The Journal of the American Society of Hematology 120 (1), 39-46, 2012 | 447 | 2012 |
| Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus A Griesmacher, M Kindhauser, SE Andert, W Schreiner, C Toma, ... The American journal of medicine 98 (5), 469-475, 1995 | 416 | 1995 |
| Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) P Collins, F Baudo, P Knoebl, H Lévesque, L Nemes, F Pellegrini, ... Blood, The Journal of the American Society of Hematology 120 (1), 47-55, 2012 | 399 | 2012 |
| International recommendations on the diagnosis and treatment of acquired hemophilia A A Tiede, P Collins, P Knoebl, J Teitel, C Kessler, M Shima, G Di Minno, ... haematologica 105 (7), 1791, 2020 | 334 | 2020 |
| Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura F Scheiflinger, P Knöbl, B Trattner, B Plaimauer, G Mohr, M Dockal, ... Blood 102 (9), 3241-3243, 2003 | 300 | 2003 |
| Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study A Tiede, R Klamroth, RE Scharf, RU Trappe, K Holstein, A Huth-Kühne, ... Blood, The Journal of the American Society of Hematology 125 (7), 1091-1097, 2015 | 286 | 2015 |
| Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura M Scully, P Knöbl, K Kentouche, L Rice, J Windyga, R Schneppenheim, ... Blood, The Journal of the American Society of Hematology 130 (19), 2055-2063, 2017 | 268 | 2017 |
| Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial P Chowdary, S Lethagen, U Friedrich, B Brand, C Hay, FA Karim, ... Journal of Thrombosis and Haemostasis 13 (5), 743-754, 2015 | 248 | 2015 |
| AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t (8; 21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. R Kusec, K Laczika, P Knöbl, J Friedl, H Greinix, P Kahls, W Linkesch, ... Leukemia 8 (5), 735-739, 1994 | 203 | 1994 |
| Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies B Plaimauer, JAK Hovinga, C Juno, MJ Wolfsegger, S Skalicky, ... journal of Thrombosis and Haemostasis 9 (5), 936-944, 2011 | 186 | 2011 |
| Redefining outcomes in immune TTP: an international working group consensus report A Cuker, SR Cataland, P Coppo, J de La Rubia, KD Friedman, JN George, ... Blood, The Journal of the American Society of Hematology 137 (14), 1855-1861, 2021 | 168 | 2021 |
| Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism M Margaglione, G D’Andrea, D Colaizzo, G Cappucci, A del Popolo, ... Thrombosis and haemostasis 82 (12), 1583-1587, 1999 | 166 | 1999 |
| Acquired haemophilia: an overview for clinical practice CM Kessler, P Knöbl European Journal of Haematology 95, 36-44, 2015 | 161 | 2015 |
| Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia U Derhaschnig, R Reiter, P Knöbl, M Baumgartner, P Keen, B Jilma Blood 102 (6), 2093-2098, 2003 | 161 | 2003 |
| Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry L Tengborn, F Baudo, A Huth‐Kühne, P Knoebl, H Lévesque, P Marco, ... BJOG: An International Journal of Obstetrics & Gynaecology 119 (12), 1529-1537, 2012 | 159 | 2012 |
| The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017 HA van Dorland, MM Taleghani, K Sakai, KD Friedman, JN George, ... Haematologica 104 (10), 2107, 2019 | 157 | 2019 |
